½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Neurological Biomarkers Market, By Biomarker Type, By Application, By End User, By Geography
»óǰÄÚµå : 1672767
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ¼¼°è ½ÃÀåÀº 2025³â¿¡´Â 96¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2032³â¿¡´Â 231¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2025-2032³âÀÇ CAGRÀº 13.3%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 96¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR 13.30% 2032³â °¡Ä¡ ¿¹Ãø 231¾ï 2,000¸¸ ´Þ·¯
±×¸². ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº°
Neurological Biomarkers Market-IMG1

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿´Â Á¤»óÀûÀÎ »ý¹°ÇÐÀû °úÁ¤°ú º´¿ø¼º °úÁ¤ÀÇ °´°üÀûÀÎ ÃøÁ¤°ú Æò°¡¿¡ µµ¿òÀÌ µË´Ï´Ù. À̵éÀº ½Å°æ ÁúȯÀÇ °ËÃâ, À§Çè Æò°¡, Áúº´ ÁøÇà ÃßÀû, Ä¡·á °³ÀÔ¿¡ ´ëÇÑ ¹ÝÀÀ ÃøÁ¤¿¡ µµ¿òÀÌ µË´Ï´Ù. ¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´, ´Ù¹ß¼º °æÈ­Áõ°ú °°Àº ½Å°æÁúȯÀÇ ¹ß»ý·ü Áõ°¡´Â ½Å·Ú¼º ÀÖ´Â ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ¼ö¿ä¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½Å°æÁúȯ¿¡ ´ëÇÑ Á¤¹ÐÀǷᳪ µ¿¹ÝÁø´ÜÀÇ °³¹ß¿¡ ÁÖ¸ñ¹Þ°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Áúº´ »ý¹°Çп¡ ´ëÇÑ ÀÌÇØ°¡ Á¦ÇѵǾî ÀÖ°í ¹ÙÀÌ¿À ¸¶Ä¿ »ç¿ë¿¡ ´ëÇÑ ÇÕÀǰ¡ ¾ò¾îÁöÁö ¾ÊÀº °ÍÀÌ ½ÃÀå ¼ºÀåÀÇ °úÁ¦°¡µÇ¾ú½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ¼¼°è ½ÃÀå ¼ºÀåÀº ÁÖ·Î ½Å°æÁúȯ ¼¼°èÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. WHOÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ½Å°æÁúȯÀº ¼¼°è¿¡¼­ 10¾ï ¸í ÀÌ»óÀÌ º´À» ¾Î°í ÀÖÀ¸¸ç, ½Å°æÁúȯÀº ¼¼°è Áúº´ ºÎ´ãÀÇ ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´¿¡ °É¸®±â ½¬¿î ³ëÀÎ Áõ°¡´Â ¼ö¿ä¸¦ ²ø¾î ¿Ã¸± ¼ö ÀÖ½À´Ï´Ù. Á¦¾à ±â¾÷¿¡ ÀÇÇÑ ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸ ¹× ÀǾàǰ °³¹ß ÅõÀÚ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª Ç¥Àû ½Äº°ºÎÅÍ »ó¿ëÈ­¿¡ À̸£´Â ÀǾàǰ °³¹ß ºñ¿ëÀÌ ³ôÀº °ÍÀº ½ÅÈï±¹ ½ÃÀå¿¡ ´ëÇÑ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ÁøÀÔÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù. Áø´Ü ¹× ÀÓ»óÀû ÀÇ»ç°áÁ¤¿¡¼­ ¹ÙÀÌ¿À¸¶Ä¿ »ç¿ë¿¡ ´ëÇÑ ÇÕÀǰ¡ ºÎÁ·ÇÏ¸é ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÐÁ¦°£ ¿¬±¸¸¦ À§ÇÑ °ü¹Î °øµ¿ ¿¬±¸ Áõ°¡´Â ½ÃÀå ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå-Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, ¹ÙÀÌ¿À¸¶Ä¿ À¯Çüº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, ¿ëµµº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ºÐ¼®°¡ Ãßõ

Á¦11Àå ¼½¼Ç

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Neurological Biomarkers Market is estimated to be valued at USD 9.64 Bn in 2025 and is expected to reach USD 23.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 9.64 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.30% 2032 Value Projection: USD 23.12 Bn
Figure. Neurological Biomarkers Market Share (%), By Region 2025
Neurological Biomarkers Market - IMG1

Neurological biomarkers help in objectively measuring and evaluating normal biological and pathogenic processes. These aid in detecting neurological disorders, assessing risk, tracking disease progression, and measuring response to therapeutic interventions. Rising incidence of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and others can boost demand for reliable neurological biomarkers. Furthermore, growing focus on development of precision medicine and companion diagnostics for neurological conditions can drive the market growth. However, limited understanding of disease biology and lack of consensus on use of biomarkers can pose challenge to market growth.

Market Dynamics:

Global neurological biomarkers market growth is primarily driven by rising prevalence of neurological disorders globally. According to the data from WHO, neurological disorders affect over a billion people worldwide with neurological conditions being a major contributor to the global burden of disease. Growing geriatric population, prone to these disorders, can boost demand. Higher investments in biomarker research and drug development by pharmaceutical players can drive the market growth. However, high cost of drug development from target identification to commercialization hampers newer biomarkers from entering the market. Lack of consensus on use of biomarkers in diagnosis and clinical decision-making can hamper the market growth. Increasing public private collaborations for interdisciplinary research can offer market growth opportunities.

Key Features of the Study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Neurological Biomarkers Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Neurological Biomarkers Market, By Biomarker Type, 2020 - 2032, (USD Bn)

6. Global Neurological Biomarkers Market, By Application, 2020 - 2032, (USD Bn)

7. Global Neurological Biomarkers Market, By End User, 2020 - 2032, (USD Bn)

8. Global Neurological Biomarkers Market, By Region, 2020 - 2032, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â